Evaluation of Antitumor Activity of Long-Circulating and pH-Sensitive Liposomes Containing Ursolic Acid in Animal Models of Breast Tumor and Gliosarcoma

Abstract

Background. Ursolic acid (UA) is a triterpene found in different plant species, possessing antitumor activity, which may be a result of its antiangiogenic effect. However, UA has low water solubility, which limits its use because the bioavailability is impaired. To overcome this inconvenience, we developed long-circulating and pH-sensitive liposomes containing ursolic acid (SpHL-UA). We investigated the antiangiogenic effect of free UA and SpHL-UA in murine brain cancer and human breast tumor models by means of determination of the relative tumor volume, dynamic contrast-enhanced magnetic resonance imaging (DCE-MRI), and histopathological analysis. Methods. The animals were treated with dimethyl sulfoxide in 0.9% (w/v) NaCl, free UA, long-circulating and pH-sensitive liposomes without drug (SpHL), or SpHL-UA. The animals were submitted to each treatment by intraperitoneal injection for 5 days. The dose of free UA or SpHL-UA was equal to 23 mg/kg. Results. Tumor growth inhibition was not observed in human breast tumor–bearing animals. For murine gliosarcoma-bearing animals, a slight tumor growth inhibition was observed in the groups treated with free UA or SpHL-UA (9% and 15%, respectively). No significant change in any of the parameters evaluated by DCE-MRI for both experimental models could be observed. Nevertheless, the evaluation of the mean values of magnetic resonance parameters of human breast tumor–bearing animals showed evidence of a possible antiangiogenic effect induced by SpHL-UA. Histopathological analysis did not present significant change for any treatment. Conclusion. SpHL-UA did not show antiangiogenic activity in a gliosarcoma model and seemed to induce an antiangiogenic effect in the human breast tumor model.

Ursolic acid: Pharmacokinetics process in vitro and in vivo, a mini review

“…CS‐UA‐L could significantly selectively accumulate at tumor tissues . The concentration of long circulating liposomes UA in tumor tissues was also higher than that of free UA after IV 12 h . The distribution of UA liposomes in tumor tissues increased significantly with the prolongation of time and gradually exceeded the free UA group…”

Naturally occurring anti-cancer compounds: shining from Chinese herbal medicine

“…UA is insoluble in water, with poor pharmacokinetic properties including poor oral bioavailability, low dissolution and weak membrane permeability [298]. Some new drug delivery technologies have been developed to overcome these problems including the uses of liposomes [280,[299][300][301][302], solid dispersions [303], niossomal gels [304], and nanoliposomes [278]. Liposome is the most commonly used drug delivery system.…”

The Role and Therapeutic Targeting of JAK/STAT Signaling in Glioblastoma

“…This strategy was insufficient in that no overall significant growth inhibition after intravenous administration was seen. Earlier efforts with liposomal modification of ursolic acid met with similar lack of anti-proliferative and anti-angiogenic activity [ 174 ]. What appears to be increasingly clear is that the chief utility of natural STAT3-inhibiting compounds lies in serving as the structural basis for synthesizing novel and more effective small molecules.…”